Specialty pharmacy network expansion

Based on increasing patient volume, we have identified an opportunity to enhance our current distribution network by adding new specialty pharmacies to effectively meet the needs of our growing EMFLAZA® (deflazacort) patient family. Effective today, PTC Therapeutics, Inc. is proud to add Amber Pharmacy and Orsini Healthcare to the EMFLAZA commercial specialty pharmacy network.

Should you have any questions about this network expansion and how it affects you or your child, please contact a PTC Cares™ Case Manager. The PTC Cares team is available from 8 am – 8 pm ET Monday – Friday. The PTC Cares team can be reached by dialing 1-844-4PTC-CARES (844-478-2227).

PTC Cares™ is a trademark of PTC Therapeutics, Inc.
Emflaza® is a registered trademark of PTC Therapeutics, Inc.
©2020 PTC Therapeutics, Inc.
US-EMF-0267v2
09/2020

Logo of PTC Cares
  • Existing Patients: Report 2021 insurance changes to avoid disruptions
  • COMPLETE THE FORM  
Skip to content
  • What is
    PTC Cares
  • Insurance
    Basics
  • Financial
    Assistance
  • Resources
  • Community
    Engagement

  • Search
PTC Cares
Skip to content
  • What is PTC Cares
    • PTC Cares Overview
    • Prescription Start Form
    • Prescription Process
    • FAQs
  • Insurance Basics
  • Financial Assistance
  • Resources
  • Community Engagement

Sitemap

  • Homepage
  • What is PTC Cares
    • PTC Cares Overview
    • Prescription Start Form
    • Prescription Process
    • FAQS
  • Insurance Basics
  • Financial Assistance
  • Resources
  • Community Engagement
  • PTC Cares™ 2021 Insurance Renewal Form
  • PTC Cares™ 2021 Insurance Renewal Spanish Form
Skip to content
  • Contact Us
  • Terms Of Use
  • Privacy Policy
  • Site map
  • Emflaza® (deflazacort)

Icon of American Flag   This site is intended for U.S. audiences only.

PTC Cares™ and Navigating Duchenne™ are trademarks of PTC Therapeutics, Inc.
Emflaza® is a registered trademark of PTC Therapeutics, Inc.
© 2020 PTC Therapeutics, Inc. All Rights Reserved. MAT-CORP-0245 11/20